March 28, 2025 - 12:32
Michael Kratsios has officially been appointed as the Director of the Office of Science and Technology Policy (OSTP) after receiving confirmation from the U.S. Senate on March 25. The vote was decisively in his favor, with a tally of 74 to 25. Nominated by President Donald Trump, Kratsios is set to play a pivotal role in shaping the nation's science and technology agenda.
In his new position, Kratsios will be responsible for guiding policies that affect a wide array of scientific and technological advancements. His role includes advising the President on innovations that are crucial for the country’s economic growth and national security. Given the rapid pace of technological change, his leadership is expected to influence how the government approaches emerging technologies and their implications for society.
Kratsios's confirmation marks a significant step in the administration's efforts to prioritize science and technology as essential components of national policy.
June 7, 2025 - 20:23
Yageo Corp. to Retain Shibaura's AI Technology in Japan Following AcquisitionTaiwan`s Yageo Corp. has announced its intention to maintain the advanced artificial intelligence technology of Shibaura Electronics Co. in Japan, contingent upon a successful acquisition of the...
June 7, 2025 - 00:28
Pankaj K. Jha Awarded NSF Grant for Quantum Technology ResearchPankaj K. Jha, a prominent professor in the field of quantum technology, has recently been awarded a significant grant from the National Science Foundation (NSF) to further his research on...
June 6, 2025 - 01:39
Utilizing Smart Manufacturing Technology for the Next Generation of CNC MachinistsIn an era marked by rapid technological advancements, the manufacturing industry faces a pressing challenge: bridging the skills gap in the workforce. As smart manufacturing technologies continue...
June 5, 2025 - 09:18
FDA Greenlights Innovative AI Tool for Enhanced Breast Cancer DetectionA groundbreaking development in breast cancer detection has received approval from the FDA. This new AI technology, created by a pioneering tech company, marks the first instance of an FDA-approved...